Valuation: Imagenetix, Inc.

Market Cap 2.56M 2.22M 2.08M 1.91M 3.59M 244M 3.66M 24.47M 9.59M 122M 9.61M 9.4M 401M P/E 2010
-5.69x
P/E 2011 -1.95x
Enterprise Value 2.49M 2.17M 2.02M 1.86M 3.5M 238M 3.56M 23.87M 9.35M 119M 9.37M 9.16M 391M EV / Sales 2010
0.45x
EV / Sales 2011 0.72x
Free-Float
36.25%
Yield 2010 *
-
Yield 2011 -
Manager TitleAgeSince
Chief Executive Officer - 2015-10-27
Director of Finance/CFO 80 2009-11-22
Chief Executive Officer 73 1998-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-31.25%-31.25% - - 5.71K
+1.53%+2.42%+36.94%+87.16% 13.64B
-4.47%-1.57%-32.80%+247.84% 7.84B
-1.15%+6.39%-12.91%-51.30% 2.59B
+4.52%-0.92%-75.86%-63.80% 1.44B
+2.50%+4.52%+33.30%-32.07% 1.29B
+1.13%+8.25%-27.84%-23.48% 1.28B
+0.17%+1.17%+22.88%+37.47% 1.22B
+0.58%-4.57%-37.12% - 1.12B
+11.20%+6.19%-63.08%-70.63% 901M
Average -1.52%+0.92%-17.39%+16.40% 3.48B
Weighted average by Cap. +0.16%+0.86%+1.31%+93.31%

Financials

2010 2011
Net sales 6.6M 5.73M 5.35M 4.91M 9.26M 629M 9.43M 63.11M 24.72M 314M 24.78M 24.23M 1.03B 7.13M 6.2M 5.78M 5.31M 10.01M 679M 10.19M 68.21M 26.71M 339M 26.78M 26.18M 1.12B
Net income -697K -606K -566K -519K -979K -66.45M -996K -6.67M -2.61M -33.14M -2.62M -2.56M -109M -2.17M -1.88M -1.76M -1.61M -3.04M -207M -3.1M -20.74M -8.12M -103M -8.14M -7.96M -340M
Net Debt -982K -853K -796K -731K -1.38M -93.55M -1.4M -9.39M -3.68M -46.65M -3.69M -3.61M -154M 740K 643K 600K 551K 1.04M 70.53M 1.06M 7.08M 2.77M 35.17M 2.78M 2.72M 116M
Logo Imagenetix, Inc.
Imagenetix, Inc. develops, formulates, markets over-the-counter, natural-based nutritional supplements and skin care products. The Company's products are offered through multiple channels of distribution, including direct marketing companies, also known as network marketing or multi-level marketing companies and chain store retailers. Its primary product is Celadrin, a product formulation, which it sells to the mass market through retailers and on a private label basis to wholesale customers. The Company licenses its intellectual property to third parties. It is focused on two medical need areas, which include human and animal conditions related to inflammation and obesity. It has researched and developed active compositions in the areas of joint health, arthritis and periodontal disease, among others. The Company sells its own branded product, Celadrin, directly to the mass markets through retail sellers. It also offers Celadrin products through wholesale customers.
Employees
-